Engaging all three pathways simultaneously drives glucose-dependent insulin secretion through the two incretin arms while adding glucagon-receptor agonism implicated in energy expenditure, the pharmacological rationale that distinguishes it from single (GLP-1 (Sema)) and dual (GLP-2 (Triz)) incretin agonists
They bind to IgE antibodies created by Th2 cells and trigger B-cells to differentiate and create IgE
Diabetic rats treated for 42 d with a daily dose of 300 mg/kg of porcine skin gelatin showed their plasma glucose AUC reduced from 30 000 to 28 000 mg min/dl (1665 to 1554 mmol min/l), insulin levels increased 2-fold, active GLP-1 levels reduced from 15 to 135 pm and DPP4 activity reduced by half (Reference Huang, Hung and Jao48)
2 Matthew Stefan, Matthew Sharp, Raad Gheith, Ryan Lowery, Charlie Ottinger, Jacob Wilson, Shane Durkee, and Aouatef Bellamine